RANDOMIZED CONTROL TRIAL: MYCOPHENOLATE MOFETIL IN PATIENTS W/ IGA NEPHROPATHY

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This multicenter clinical trial tests the efficacy of Mycophenolate Mofetil in reducing proteinuria, which is usually equated with improvement in prognosis, in patients with IgA Nephropathy who are being maintained on a standard regimen of an angiotensin converting enzyme inhibitor and fish oil supplements.